Thomas Schirrmann

Braunschweig, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Novel bispecific T-cell engagers overcoming acquired EGFR resistance.

Novel bispecific T-cell engagers overcoming acquired EGFR resistance.

Journal: mAbs

Published: May 19, 2026

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.

The landscape of antibody production systems: recombinant expression for research, diagnostics and therapy.

Journal: Frontiers in bioengineering and biotechnology

Published: December 15, 2025

A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies.

A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodies.

Journal: mAbs

Published: October 13, 2025

A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers.

A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers.

Journal: mAbs

Published: September 22, 2025

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.

Evaluation of the Neutralizing Antibody STE90-C11 against SARS-CoV-2 Delta Infection and Its Recognition of Other Variants of Concerns.

Journal: Viruses

Published: September 23, 2023

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.

Journal: Frontiers in immunology

Published: May 23, 2023

Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.

Characterization of an In Vivo Neutralizing Anti-Vaccinia Virus D8 Single-Chain Fragment Variable (scFv) from a Human Anti-Vaccinia Virus-Specific Recombinant Library.

Journal: Vaccines

Published: September 30, 2021

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Journal: Frontiers in cellular and infection microbiology

Published: May 06, 2021

Title Not Found

Title Not Found

Journal: Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)

Published: February 22, 2021

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.

Journal: Cell reports

Published: December 02, 2020

Title Not Found

Title Not Found

Journal: Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)

Published: August 25, 2020

Screening for scFv-fragments that are stable and active in the cytosol.

Screening for scFv-fragments that are stable and active in the cytosol.

Journal: Human antibodies

Published: March 03, 2020

Showing 1-12 of 42

Last Updated: 09/26/2026